HK2 and hepatocellular carcinoma: Our findings reveal P3H4 as a novel regulator of glycolytic metabolism in HCC, where its KD significantly reduced glucose consumption, lactate production, and ATP levels while decreasing expression of key glycolytic enzymes HK2 and LDHA.